Location Israel, Asia Regions Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) Gender Male
LinkedIn View on LinkedIn
Dr. Aharon joined Chemomab in 2016 as Head of Clinical Development. Prior to Chemomab, Dr. Aharon served as Chief Medical Officer at BioLineRx Ltd. (NASDAQ/TASE: BLRX), where he directed the development pipeline for oncology and immunology. Dr. Aharon’s professional experience includes multiple senior management positions at biotechnology
companies, such as Pharmos Ltd. (NASDAQ/TASE: PARX), Thrombotech Ltd., and LycoRed Ltd. Dr. Aharon is a member of several industry advisory groups and provides consulting services to biotechnology companies and academic institutions. Dr. Aharon earned his MD from the University of Tel Aviv, Israel, and has experience in internal medicine.
